These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38630712)

  • 21. Rheumatoid arthritis and citrullination.
    Darrah E; Andrade F
    Curr Opin Rheumatol; 2018 Jan; 30(1):72-78. PubMed ID: 28937414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients.
    Xu M; Du R; Xing W; Chen X; Wan J; Wang S; Xiong L; Nandakumar KS; Holmdahl R; Geng H
    Front Immunol; 2023; 14():1084283. PubMed ID: 36761728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
    Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
    Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
    Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D
    Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis.
    Darrah E; Kim A; Zhang X; Boronina T; Cole RN; Fava A; Giles JT; Bingham III CO; Chalmers MJ; Griffin PR; Sadegh-Nasseri S; Rosen A
    J Proteome Res; 2017 Jan; 16(1):355-365. PubMed ID: 27700100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance.
    van Beers JJ; Raijmakers R; Alexander LE; Stammen-Vogelzangs J; Lokate AM; Heck AJ; Schasfoort RB; Pruijn GJ
    Arthritis Res Ther; 2010; 12(6):R219. PubMed ID: 21182780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases.
    Holmes CL; Shim D; Kernien J; Johnson CJ; Nett JE; Shelef MA
    J Immunol Res; 2019; 2019():2160192. PubMed ID: 30993117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis.
    Sokolove J; Brennan MJ; Sharpe O; Lahey LJ; Kao AH; Krishnan E; Edmundowicz D; Lepus CM; Wasko MC; Robinson WH
    Arthritis Rheum; 2013 Jul; 65(7):1719-24. PubMed ID: 23553485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
    Vossenaar ER; Radstake TR; van der Heijden A; van Mansum MA; Dieteren C; de Rooij DJ; Barrera P; Zendman AJ; van Venrooij WJ
    Ann Rheum Dis; 2004 Apr; 63(4):373-81. PubMed ID: 15020330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
    Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
    Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
    Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
    Front Immunol; 2018; 9():3033. PubMed ID: 30662440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
    Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
    J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
    Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
    Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.
    Wagner CA; Sokolove J; Lahey LJ; Bengtsson C; Saevarsdottir S; Alfredsson L; Delanoy M; Lindstrom TM; Walker RP; Bromberg R; Chandra PE; Binder SR; Klareskog L; Robinson WH
    Ann Rheum Dis; 2015 Mar; 74(3):579-86. PubMed ID: 24297382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.
    Shelef MA; Sokolove J; Lahey LJ; Wagner CA; Sackmann EK; Warner TF; Wang Y; Beebe DJ; Robinson WH; Huttenlocher A
    Arthritis Rheumatol; 2014 Jun; 66(6):1482-91. PubMed ID: 24497204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations.
    Ferucci ED; Darrah E; Smolik I; Choromanski TL; Robinson DB; Newkirk MM; Fritzler MJ; Rosen A; El-Gabalawy HS
    J Rheumatol; 2013 Sep; 40(9):1523-8. PubMed ID: 23908443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.
    Shi J; Darrah E; Sims GP; Mustelin T; Sampson K; Konig MF; Bingham CO; Rosen A; Andrade F
    Ann Rheum Dis; 2018 Jan; 77(1):141-148. PubMed ID: 29070531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
    Vitkov L; Hannig M; Minnich B; Herrmann M
    Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
    Konig MF; Giles JT; Nigrovic PA; Andrade F
    Ann Rheum Dis; 2016 Nov; 75(11):2022-2028. PubMed ID: 26865600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
    Umeda N; Matsumoto I; Kawaguchi H; Kurashima Y; Kondo Y; Tsuboi H; Ogishima H; Suzuki T; Kagami Y; Sakyu T; Ishigami A; Maruyama N; Sumida T
    Clin Rheumatol; 2016 May; 35(5):1181-8. PubMed ID: 26415740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.